Invitae Corp

2023 Q4 Form 10-Q Financial Statement

#000150113423000104 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $254.6M
YoY Change -56.55%
Cash & Equivalents $158.0M
Short-Term Investments $96.57M
Other Short-Term Assets $19.70M
YoY Change -20.18%
Inventory $21.63M
Prepaid Expenses
Receivables $82.51M
Other Receivables $0.00
Total Short-Term Assets $378.4M
YoY Change -48.14%
LONG-TERM ASSETS
Property, Plant & Equipment $65.45M
YoY Change -42.53%
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $19.53M
YoY Change -9.23%
Total Long-Term Assets $156.7M
YoY Change -87.91%
TOTAL ASSETS
Total Short-Term Assets $378.4M
Total Long-Term Assets $156.7M
Total Assets $535.1M
YoY Change -73.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.19M
YoY Change 134.78%
Accrued Expenses $84.73M
YoY Change 1.94%
Deferred Revenue $4.788M
YoY Change -15.45%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $30.90M
YoY Change 485.34%
Total Short-Term Liabilities $158.4M
YoY Change 39.8%
LONG-TERM LIABILITIES
Long-Term Debt $1.325B
YoY Change -16.88%
Other Long-Term Liabilities $226.0K
YoY Change -98.22%
Total Long-Term Liabilities $226.0K
YoY Change -98.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $158.4M
Total Long-Term Liabilities $226.0K
Total Liabilities $1.619B
YoY Change -13.33%
SHAREHOLDERS EQUITY
Retained Earnings -$6.200B
YoY Change 31.1%
Common Stock $29.00K
YoY Change 20.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.083B
YoY Change
Total Liabilities & Shareholders Equity $535.1M
YoY Change -73.59%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001501134
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Invitae Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1701898
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
374-7782
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
NVTA
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257489000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
96566000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
289611000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82507000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96148000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
21627000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
30386000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19692000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19496000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106563000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10100000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10030000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1012549000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19531000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23121000 usd
CY2023Q3 us-gaap Assets
Assets
535115000 usd
CY2022Q4 us-gaap Assets
Assets
1954116000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
25185000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13984000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17650000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14600000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3948000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5121000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133536000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
116956000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58336000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
877289000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
125222000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
37760000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1872000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
5850000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
14145000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-948278000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-302224000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6171000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1068000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-301156000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275604000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
275604000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-942107000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-301156000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-61000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
436000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
16529000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-925639000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-300720000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
1400 16th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94103
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
286492840 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
158007000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
378399000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
693130000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65446000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108723000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61639000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
84729000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
74388000 usd
CY2023Q3 nvta Convertible Debt Fair Value Disclosures Current
ConvertibleDebtFairValueDisclosuresCurrent
26907000 usd
CY2022Q4 nvta Convertible Debt Fair Value Disclosures Current
ConvertibleDebtFairValueDisclosuresCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
158419000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
108093000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
134945000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
134386000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
855000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3780000 usd
CY2023Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
122333000 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1127830000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1470783000 usd
CY2023Q3 nvta Convertible Debt Fair Value Disclosures Noncurrent
ConvertibleDebtFairValueDisclosuresNoncurrent
196244000 usd
CY2022Q4 nvta Convertible Debt Fair Value Disclosures Noncurrent
ConvertibleDebtFairValueDisclosuresNoncurrent
0 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8130000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
226000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4775000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1618519000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1852280000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
25000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
25378000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5061131000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4931032000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6169942000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4829141000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1083404000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
101836000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
535115000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1954116000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121241000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359129000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
393849000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
82186000 usd
us-gaap Cost Of Revenue
CostOfRevenue
258102000 usd
us-gaap Cost Of Revenue
CostOfRevenue
324412000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87177000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
184138000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
330559000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37999000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49193000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
127241000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
172086000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45619000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44939000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
160826000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
147221000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2313047000 usd
us-gaap Restructuring Charges
RestructuringCharges
1010843000 usd
us-gaap Restructuring Charges
RestructuringCharges
130039000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
1101429000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
423487000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1741150000 usd
us-gaap Costs And Expenses
CostsAndExpenses
3417364000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-980188000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-289951000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1382021000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3023515000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
229000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10593000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
845000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20704000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2023Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
33463000 usd
CY2022Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
72386000 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 usd
CY2023Q3 nvta Fair Value Adjustment Of Acquisition Related Liabilities
FairValueAdjustmentOfAcquisitionRelatedLiabilities
-70000 usd
CY2022Q3 nvta Fair Value Adjustment Of Acquisition Related Liabilities
FairValueAdjustmentOfAcquisitionRelatedLiabilities
527000 usd
nvta Fair Value Adjustment Of Acquisition Related Liabilities
FairValueAdjustmentOfAcquisitionRelatedLiabilities
-337000 usd
nvta Fair Value Adjustment Of Acquisition Related Liabilities
FairValueAdjustmentOfAcquisitionRelatedLiabilities
-15666000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4843000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2399000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15105000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3971000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
56531000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19637000 usd
us-gaap Interest Expense
InterestExpense
23366000 usd
us-gaap Interest Expense
InterestExpense
42149000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1348856000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3046027000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8055000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39551000 usd
nvta Noncash Lease Income Expense
NoncashLeaseIncomeExpense
-6832000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2211000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1314000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13641000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22903000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8759000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3614000 usd
nvta Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
196000 usd
nvta Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-9012000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
139000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2740000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8135000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6345000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6966000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-942107000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1340801000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3006476000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.42
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.42
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.91
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237974000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237974000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
263210000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
263210000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232889000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232889000 shares
us-gaap Net Income Loss
NetIncomeLoss
-1340801000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3006476000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
92000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-891000 usd
us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
25366000 usd
us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
0 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1315343000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3007367000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1083404000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
158866000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1083404000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
158866000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1340801000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3006476000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2313047000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1012360000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-60317000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100403000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104726000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
85554000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
164314000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5483000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11676000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10593000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
nvta Amortization Of Debt Issuance Costs For Exchange Of Notes
AmortizationOfDebtIssuanceCostsForExchangeOfNotes
20704000 usd
nvta Amortization Of Debt Issuance Costs For Exchange Of Notes
AmortizationOfDebtIssuanceCostsForExchangeOfNotes
0 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
72386000 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 usd
nvta Business Combination Remeasurement Of Liabilities
BusinessCombinationRemeasurementOfLiabilities
-337000 usd
nvta Business Combination Remeasurement Of Liabilities
BusinessCombinationRemeasurementOfLiabilities
-15666000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8055000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-39551000 usd
nvta Share Based Payment Arrangement Noncash Expense Acceleration Of Unvested Equity
ShareBasedPaymentArrangementNoncashExpenseAccelerationOfUnvestedEquity
1789000 usd
nvta Share Based Payment Arrangement Noncash Expense Acceleration Of Unvested Equity
ShareBasedPaymentArrangementNoncashExpenseAccelerationOfUnvestedEquity
4980000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6259000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-603000 usd
nvta Noncash Lease Income Expense
NoncashLeaseIncomeExpense
-9309000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-540000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-156198000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-410934000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
231044000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
789622000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
430440000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
541313000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4669000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48385000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
332000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
195059000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-296694000 usd
nvta Proceeds From Issuance Of Public Offerings Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts
-55000 usd
nvta Proceeds From Issuance Of Public Offerings Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfPublicOfferingsOfCommonStockNetOfIssuanceCosts
9658000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2170000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6267000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
30001000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
25974000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
135000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3886000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4184000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5529000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
10582000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138273000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1159000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-99412000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-706469000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267519000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
933525000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168107000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227056000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4472000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
764000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2531000 usd
us-gaap Stock Issued1
StockIssued1
413000 usd
us-gaap Stock Issued1
StockIssued1
4274000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
320039000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
301171000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4495000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6200000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4800000000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3100000000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-379000000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-602200000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-493000000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-559800000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-298500000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-942100000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-301200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1300000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3000000000 usd
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-881200000 usd
CY2022Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-55500000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1000000000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2300000000 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
60300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-156200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-410900000 usd
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
254600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
547100000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base these estimates on current facts, historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including assumptions as to </span></div>future events. Actual results could differ materially from those judgments, estimates and assumptions. We evaluate our estimates on an ongoing basis.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior period reclassifications</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. L</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oss on disposal of property and equipment and impairment charges related to right-of-use assets and the related leasehold improvements are now included in restructuring, impairment and other costs in the condensed consolidated statements of operations. This reclassification had no effect on the previously reported results of operations.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk and other risks and uncertainties</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, restricted cash, marketable securities and accounts receivable. Our cash and cash equivalents are primarily held by financial institutions in the United States. Such deposits often exceed federally insured limits.</span></div>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
158007000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217029000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10100000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10027000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168107000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227056000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121241000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133536000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359129000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
393849000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1800000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1300000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1900000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2300000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4800000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4800000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
100000 usd
CY2023Q3 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
1600000 usd
CY2022Q4 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
4700000 usd
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one to six months
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1200702000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
270075000 usd
CY2023Q3 nvta Finite Lived Intangible Assets Disposals And Accumulated Impairments
FiniteLivedIntangibleAssetsDisposalsAndAccumulatedImpairments
930627000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y1M6D
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1257246000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
207688000 usd
CY2022Q4 nvta Finite Lived Intangible Assets Disposals And Accumulated Impairments
FiniteLivedIntangibleAssetsDisposalsAndAccumulatedImpairments
37009000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1012549000 usd
CY2022Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y9M18D
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25600000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81900000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79800000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2300000000 usd
CY2022Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
30000000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4800000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
788700000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
788700000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
21368000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29992000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
259000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
382000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
21627000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
30386000 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
700000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
134731000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
179296000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69285000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70573000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65446000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108723000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
5200000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
9700000 usd
us-gaap Depreciation
Depreciation
15600000 usd
us-gaap Depreciation
Depreciation
21100000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8500000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-21600000 usd
CY2023Q1 us-gaap Long Term Debt Term
LongTermDebtTerm
P5Y7D
CY2023Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P3Y
CY2023Q3 us-gaap Finance Lease Impairment Loss
FinanceLeaseImpairmentLoss
800000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
400000 usd
us-gaap Sublease Income
SubleaseIncome
1100000 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
14219859 shares
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39345000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25315000 usd
CY2023Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
20761000 usd
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
905000 usd
CY2023Q3 nvta Accrued Expenses Current
AccruedExpensesCurrent
14349000 usd
CY2022Q4 nvta Accrued Expenses Current
AccruedExpensesCurrent
23628000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4788000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4814000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3265000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4568000 usd
CY2023Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2176000 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3177000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
45000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6646000 usd
CY2023Q3 nvta Business Combination Accrued Liabilities Current
BusinessCombinationAccruedLiabilitiesCurrent
0 usd
CY2022Q4 nvta Business Combination Accrued Liabilities Current
BusinessCombinationAccruedLiabilitiesCurrent
5335000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
84729000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
74388000 usd
CY2023Q3 nvta Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost
CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
259979000 usd
CY2023Q3 nvta Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax
CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
19000 usd
CY2023Q3 nvta Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Loss Before Tax
CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
8000 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
153324000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10100000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
96566000 usd
CY2023Q3 nvta Cash Equivalents Restricted Cash And Marketable Securities Fair Value
CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
259990000 usd
CY2023Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
196244000 usd
CY2023Q3 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
25000 usd
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
196269000 usd
CY2022Q4 nvta Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost
CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
448622000 usd
CY2022Q4 nvta Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Gain Before Tax
CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedGainBeforeTax
56000 usd
CY2022Q4 nvta Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost Gross Unrealized Loss Before Tax
CashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCostGrossUnrealizedLossBeforeTax
136000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
148901000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10030000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
289611000 usd
CY2022Q4 nvta Cash Equivalents Restricted Cash And Marketable Securities Fair Value
CashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
448542000 usd
CY2022Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
769000 usd
CY2022Q4 nvta Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0 usd
CY2023Q3 nvta Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2200000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6500000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5000000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
36100000 usd
CY2023Q3 us-gaap Long Term Debt Term
LongTermDebtTerm
P4Y5M15D
CY2023Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
15819604 shares
CY2023Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
11600000 usd
CY2022Q3 nvta Royalty Rate
RoyaltyRate
0.07
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
14219859 shares
CY2023Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
15819604 shares
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25997000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60413000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85554000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
164314000 usd
CY2023Q2 nvta Share Based Payment Arrangement Retention Related Rs Us Issued Number Of Employees
ShareBasedPaymentArrangementRetentionRelatedRSUsIssuedNumberOfEmployees
2 employees
CY2023Q3 us-gaap Severance Costs1
SeveranceCosts1
1022000 usd
CY2022Q3 us-gaap Severance Costs1
SeveranceCosts1
57903000 usd
us-gaap Severance Costs1
SeveranceCosts1
2285000 usd
us-gaap Severance Costs1
SeveranceCosts1
57903000 usd
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-881165000 usd
CY2022Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-55500000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1012360000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-60317000 usd
CY2023Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
-4898000 usd
CY2022Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
11819000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
-3802000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
11819000 usd
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
877289000 usd
CY2022Q3 us-gaap Restructuring Costs
RestructuringCosts
125222000 usd
us-gaap Restructuring Costs
RestructuringCosts
1010843000 usd
us-gaap Restructuring Costs
RestructuringCosts
130039000 usd
CY2022Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
1000 employee
nvta Restructuring And Related Costs Gain Loss On Extinguishment Of Contractual Liability
RestructuringAndRelatedCostsGainLossOnExtinguishmentOfContractualLiability
5500000 usd
CY2023Q3 nvta Restructuring And Related Costs Gain Loss On Extinguishment Of Contractual Liability
RestructuringAndRelatedCostsGainLossOnExtinguishmentOfContractualLiability
5500000 usd
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2022 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
42642000 usd
CY2022 us-gaap Payments For Restructuring
PaymentsForRestructuring
38438000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
4204000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
4094000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
6326000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
1972000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6200000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39600000 usd
nvta Effective Income Tax Rate Reconciliation Amortization And Impairment Of Foreign Acquired Intangibles Amount
EffectiveIncomeTaxRateReconciliationAmortizationAndImpairmentOfForeignAcquiredIntangiblesAmount
-6500000 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1600000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
59300000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
200000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-942107000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-301156000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1340801000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3006476000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275604000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
275604000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237974000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237974000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
263210000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
263210000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232889000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232889000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.42
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.42
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.91
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
168453000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62284000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
139491000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62456000 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121241000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133536000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359129000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
393849000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
nvta-20230930_def.xml Edgar Link unprocessable
0001501134-23-000104-index-headers.html Edgar Link pending
0001501134-23-000104-index.html Edgar Link pending
0001501134-23-000104.txt Edgar Link pending
0001501134-23-000104-xbrl.zip Edgar Link pending
exhibit311-q3_2023.htm Edgar Link pending
exhibit312-q3_2023.htm Edgar Link pending
exhibit321-q3_2023.htm Edgar Link pending
exhibit322-q3_2023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
invitae-ex104x2015stockinc.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nvta-20230930.htm Edgar Link pending
nvta-20230930.xsd Edgar Link pending
nvta-20230930_g1.jpg Edgar Link pending
nvta-20230930_g2.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nvta-20230930_cal.xml Edgar Link unprocessable
nvta-20230930_lab.xml Edgar Link unprocessable
nvta-20230930_pre.xml Edgar Link unprocessable
nvta-20230930_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending